@inproceedings{inproceedings, title = {{EXPLORATORY COST EFFECTIVENESS ANALYSIS OF BEVACIZUMAB IN ADDITION TO FOLFOX-4 IN THE ADJUVANT TREATMENT OF STAGE III COLON CANCER: A UK PERSPECTIVE}}, url = {{}}, year = {{2008}}, month = {{11}}, author = {{Ducournau P and Latimer N and Sabate E and Walzer S}}, volume = {{11}}, journal = {{VALUE HEALTH}}, issue = {{6}}, pages = {{A471-A472}}, note = {{Accessed on 2025/08/14}}}